cause life-threatening complications, although the majority of AVMs remain asymptomatic. 7 AVMs are arteries and veins that seem to fuse without intervening capillaries to form a network of direct high-flow arteriovenous shunts. 8 They form at the interface between arteries and veins where the capillary bed normally lies and are thought to arise from smaller lesions, such as telangiectasia by progressive vascular remodeling. 9 Typically present at birth in the brain, they may develop and grow over time in the lung and liver, although there is still little direct evidence to support this idea. 7 Nevertheless, the recent development of mouse models for HHT and intravital imaging technologies have provided important insights into the mechanisms of AVM formation. 10 Heterozygous Eng +/− and Acvrl1 +/− mice, which are the closest animal models of HHT in terms of genotype, surprisingly develop a relatively normal vasculature with no major defects during developmental angiogenesis. However, some vascular lesions appear in these mice but only at low frequency and in an unpredictable manner. This suggests that additional triggers are needed for AVM development. [11] [12] [13] Local homozygous loss of Eng or Acvrl1 gene expression, neoangiogenesis, inflammation, and wounding have been implicated triggering arteriovenous shunt formation, in accordance with secondary triggers acting as underlying mechanisms. Ectopic expression of vascular endothelial growth factor, the prime angiogenic growth factor, using adeno-associated viruses has been shown to induce cerebrovascular dysplasia in both HHT1 and HHT2 mouse models. 14, 15 Inflammation induces endoglin protein null locally 16 that may increase the risk of vascular abnormalities in Eng +/− mice. 13 Postnatal homologous loss of the Eng or Acvrl1 gene in endothelial cells leads to the formation of arteriovenous shunts resembling those seen in HHT individuals only in sites where angiogenesis is active, supporting an hypothesis that at least 3 hits-the loss of both Eng and Acvrl1 alleles combined with environmental proangiogenic triggers-are necessary for AVM development. 10 How mutations in the Eng and Acvrl1 genes lead to AVM formation is still poorly understood, although recent findings indicate that aberrant angiogenesis may account for the development of such vessel abnormalities. 10 Although the initial stages of AVM formation occur irrespective of blood flow, this process is further exacerbated by flow. [17] [18] [19] High-velocity turbulent arterial blood flow results in dilatation and tortuosity of the downstream veins in the skin of mice harboring homologous deletion of Acvrl1 17 and promotes mural cell coverage of AVMs in Eng-iKO mice. 18 In zebrafish, activin receptor-like kinase 1 (ALK1) acts downstream of blood flow to limit the number of endothelial cells maintaining the vessel caliber.
In agreement, arteries of zebrafish harboring alk1 mutations deliver a greater blood volume to the downstream vessels that in turn adapt by enlarging and retaining arteriovenous connections that are normally transient during angiogenesis to normalize hemodynamic forces. This vessel remodeling seems to represent a normal adaptive response to increased blood flow. 19 It is not known how ALK1 regulates arterial vessel caliber. Two flow responsive genes, cxcr4a and edn1, have been proposed to act downstream of ALK1 to control vessel diameter. These genes encode a proangiogenic chemokine receptor and a vasoconstrictive peptide, respectively, although additional experiments are required to establish their functions during AVM development in HHT. 19, 20 Here, we describe cooperation between ALK1 and connexin40 (Cx40) in the regulation of blood vessel caliber. The study revealed that reduced expression of Cx40 results in enlargement of the arterial vessels in HHT2 mice and that consequent altered blood flow precipitates flow-dependent adaptive responses involving rarefaction of the capillary network and the formation of direct arteriovenous connections. This cooperation is sufficient to trigger arteriovenous shunt formation during active angiogenesis and on additional environmental insult, which resembles vascular lesions seen in patients with HHT. Our data suggest that GJA5 might be a genetic modifier in HHT2.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

BMP9/ALK1 Regulates Endothelial Cx40 Expression
Both circumferential strain and wall shear stress affect endothelial gene expression, so that these mechanical forces can be transduced to biochemical signals that facilitate adaptation to changes in blood flow. As ALK1 expression requires blood flow, it is reasonable to assume that this receptor might lie in a mechanotransduction pathway either upstream or downstream of known mechanoresponsive genes. However, these genes need to be identified. Here, we revealed that BMP9 stimulation of human arterial endothelial cells not only induced expression of ID1 and HEY2 ( Figure 1A and 1B), common downstream targets of ALK1 and Notch signaling pathways, 21 but also strongly stimulated the expression of GJA5 to levels ≈20-fold higher than the untreated cells after 24 hours of growth factor addition ( Figure 1C ). BMP9 has been shown to activate ALK1-inducing Smad1/5 phosphorylation in endothelial cells. 5 To examine whether ALK1 controls GJA5 expression, we analyzed the effect of siRNA-mediated knockdown of ALK1 on BMP9-induced GJA5 in human arterial endothelial cells. siRNA-mediated downregulation of ALK1 expression was confirmed by quantitative polymerase chain reaction ( Figure 1D ). We validated that Smad1/5 phosphorylation was reduced ( Figure 1E ) and importantly found that GJA5 mRNA expression was blocked ( Figure 1F ) when ALK1 was decreased in endothelial cells stimulated by BMP9. Among the endothelial connexins, Cx40, which is highly expressed in arterial vessels, is essential for the effective transduction of vasodilatation. [22] [23] [24] [25] In sections of human skin biopsies stained for Cx40 and platelet-endothelial cell adhesion molecule-1 as a marker of endothelial cells ( Figure 1G ), we compared 5 control samples with samples isolated from 4 individuals with HHT2. All of these patients had severe HHT-related nosebleeds: the recurrent epistaxis (often 4 incidents per day) did not improve with the regular argon plasma treatment or medication-like tranexamine acid and N-acetylcysteine. Hemoglobin levels were generally low: for 1 patient, for example, they varied from 4.4 to 8.0 mmol/L for a 5-year period, and 56 blood transfusions with monthly iron transfusions were necessary to maintain normal blood levels. This patient was also treated with thalidomide with benefit but stopped because of neuropathy side effects. 26 Another had recurrent epistaxis particularly at night and was also diagnosed with atrial fibrillation. All 4 patients underwent a Saunders procedure in which their nasal epithelium was partially replaced by skin of their upper arm because of the severity of their symptoms. The surplus skin from the Saunders surgery was frozen and sectioned for analysis of Cx40 expression by immunofluorescence. Cx40 intensity levels were defined as the ratio of the Cx40-integrated intensity to the vessel surface measured as platelet-endothelial cell adhesion molecule-1-positive pixels. Cx40 protein levels were particularly low in HHT2 individuals compared with control biopsies ( Figure 1H ), suggesting that the downregulation of Cx40 expression levels in HHT2 individuals is most probably caused by the fact that the remaining wildtype ACVRL1 allele is unable to contribute protein for normal vascular functions. Our data support an association between ALK1 signaling and Cx40 expression in vivo.
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Reduced Levels of Cx40 Affect Angiogenesis in Acvrl1 +/− Mice
To investigate whether Acvrl1 and Gja5 function in the same pathway, we took advantage of the Acvrl1 +/− mutant mice that develop vascular lesions similar to those in patients with HHT2 only at low frequency and in an unpredictable, age-dependent manner. 12 We generated Acvrl1 +/− ; Gja5 EGFP/+ mice that have reduced expression of both genes as validated by quantitative polymerase chain reaction ( Figure IA and IB in the online-only Data Supplement) and first examined the neonatal retina. Gja5 EGFP/+ mice are normally viable and fertile without cardiovascular abnormalities. 27 The retinal vasculature of the single or double heterozygotes at postnatal day 7 (P7) showed a regular alternating pattern of arteries and veins with an intervening capillary network as in control mice (Figure 2A ). Endothelial tip cells formed filopodial protrusions at the sprouting front of the plexus (Figure 2A ). However, Acvrl1 +/− retinas showed excessive angiogenesis with a denser and more highly branched vascular plexus at the front, as previously reported in Acvrl1-iKO mutants 28 (Figure 2A-2C ). By contrast, Acvrl1 +/− ; Gja5 EGFP/+ mutant mice reproducibly showed reduced angiogenesis with much less dense postarteriolar capillary plexus ( Figure 2B ) that had fewer branch points ( Figure 2C ). By comparison, capillaries in other regions seemed unaffected ( arterial segments close to the optic disc and for some of the first arterial branches 29 ( Figure IIA in the online-only Data Supplement). Interestingly, the reduced number of capillaries was in areas where the blood flow is estimated to be relatively high (Figure 2A -2C; Figure IIA in the online-only Data Supplement). 29 Moreover, mural cell coverage of the arteries was enhanced in Acvrl1 +/− ; Gja5 EGFP/+ mutant mice at P7 compared with single heterozygous and wild-type littermates as revealed by staining for α-smooth muscle actin (α-SMA). Arterioles where only few α-SMA-positive cells would be normally found at P7 were covered by regular layers of smooth muscle cells, especially near their branch points with the arteries ( Figure 2D-2F ). In agreement, Gja5 expression that correlates with the arterial flow pattern was strongly increased in the arterial vessels of Acvrl1 +/− ; Gja5 EGFP/+ P7 mutant mice compared with Gja5 EGFP/+ heterozygous mice as revealed by enhanced green fluorescent protein (EGFP), suggesting that the blood flow is perturbed in the Acvrl1 +/− ; Gja5 EGFP/+ mutant mice ( Figure 2D ). To eliminate adaptive processes that may occur during embryonic development, in particular those related to blood flow regulation, confounding the analysis, we generated Acvrl1 Flox/+ ; cdh5 (PAC)-Cre ERT2 (Acvrl1-iHET); Gja5 EGFP/+ mice in which tamoxifen injection of neonatal mice led to efficient reduction of Acvrl1 mRNA expression to generate Acvrl1 +/− ; Gja5 EGFP/+ mice ( Figure IIIA and IIIB in the online-only Data Supplement). 30, 31 Impaired angiogenesis was much more severe in Acvrl1-iHET; Gja5 EGFP/+ mice than in Acvrl1 +/− ; Gja5 EGFP/+ mice, with particularly strong inhibition of postarterial capillary plexus density ( Figure IIID and IIIE in the online-only Data Supplement). This confirmed that ALK1 signaling regulates angiogenesis by directly cooperating with Cx40. Thus, reduced Cx40 in HHT2 mice disrupts proper formation of the capillary bed connecting the artery and vein.
Low Levels of Cx40 Leads to Arteriovenous Shunts in Acvrl1 +/− Retinas
Because arteriovenous shunts are thought to arise from an abnormal capillary bed, we next explored the possibility that reduced levels of Cx40 promote AVM development in Acvrl1 +/− retinas. We defined vessels ≥12.5 μm as arteriovenous shunts because arteriovenous connections of this diameter were not observed in control or single heterozygous mice at P7 ( Figure 3A-3D ). Arteriovenous shunts occurred in 71% (n=14) of the Acvrl1 +/− ; Gja5 EGFP/+ P7 mice but were completely absent in control, Acvrl1 +/− , or Gja5 EGFP/+ mice. The arteriovenous shunts were found to arise from the capillary bed starting at the postarterial capillary vessels to form enlarged vessels that connected directly to the veins ( Figure  3E) . Similar phenotypes were observed in Acvrl1-iHET; Gja5 EGFP/+ mice with a prevalence of 61% (n=13; Figure  IVA in the online-only Data Supplement). Acvrl1-iHET mice did not develop any arteriovenous shunts ( Figure IVA in the online-only Data Supplement). To determine whether the increase in AVM diameter was attributable to the increased endothelial cell number, we performed bromodeoxyuridine analysis of isolectin b4-stained vessels. In Acvrl1-iHET; Gja5 EGFP/+ mice, the number of bromodeoxyuridine-labeled endothelial cells was significantly higher than in the other genotypes, particularly in the capillary plexus where arteriovenous connections were found ( Figure IVB in the onlineonly Data Supplement). Moreover, these arteriovenous shunts lacked smooth muscle cell coverage (not shown). Because increased mural cell coverage of the AVM has been proposed to be a secondary response to increased blood flow, our data indicated that the arteriovenous shunts found in the Acvrl1 +/− ; Gja5 EGFP/+ mutant mice at P7 might represent an early stage of AVM formation. Thus, our data are consistent with a primary abnormality at the capillary level and point to vessel enlargement promoting the development of AVM.
Low Levels of Cx40 Promote the Production of Reactive Oxygen Species and Lead to Arterial Dilation in Acvrl1 +/− Mice
To explore the possibility that the enlargement of capillarylike vessels plays a causal role in the development of AVM, we examined the vasculature in the dorsal ear skin of Acvrl1 +/− ; Gja5 EGFP/+ adult mice. This area of skin has recently proven extremely useful for intravital vascular imaging and is widely used to follow AVM development in real time, particularly in wound healing. 17 We stained whole-mounts of 3-month-old mouse ears for platelet-endothelial cell adhesion molecule-1 and α-SMA ( Figure 4A ). This staining showed that the overall vessel patterning in Acvrl1 +/− ; Gja5 EGFP/+ mice was similar to that in control, Gja5 EGFP/+ , or Acvrl1 +/− mice ( Figure 4A ). The vascular network forming a finger-like architecture of larger veins that localize together with arteries that were stained for α-SMA ( Figure 4A ). However, the main arteries in the ear skin were reproducibly enlarged in Acvrl1 +/− ; Gja5 EGFP/+ adult mice compared with control, Acvrl1 +/− , or Gja5 EGFP/+ mice ( Figure 4A and 4B) . Interestingly, the latter seems to occur from early development as seen in the mesencephalic artery of embryonic day 12.5 embryos ( Figure VA -VC in the onlineonly Data Supplement) and in the lung and intestine tissue of embryonic day 17.5 embryos ( Figure VD in the online-only Data Supplement). We next investigated the Gja5 expression pattern by following EGFP expression as an indicator of hemodynamic changes and capillary arterialization. In the Gja5 EGFP/+ mice, EGFP expression was restricted to the main arteries and first arteriole branches (data not shown) copying the α-SMA staining ( Figure 4A ). By contrast, Acvrl1 +/− ; Gja5 EGFP/+ mice showed numerous enlarged prearteriolar capillaries that expressed EGFP (not shown) or α-SMA ( Figure 4A ) compared with Gja5 EGFP/+ mice. Quantification of the number of branch points and the length of the EGFP (+) vascular networks revealed an arterialization of the blood capillary bed in Acvrl1 +/− ; Gja5 EGFP/+ mice ( Figure 4C and 4D). We explored how reduced Gja5 expression affects the arterial vessel functionalities in Acvrl1 +/− mice. We examined the spontaneous oscillation in tone of the skin arterial vessels ( Figure 4E ) and the ability of the retinal arteries to constrict after an electric stimulation ( Figure 4F ). The arterial responses of Acvrl1 +/− , Gja5 EGFP/+ mice did not differ from the control, Gja5 EGFP/+ , or Acvrl1 +/− mice ( Figure 4E and 4F ), suggesting that the functionalities of the arteries are not defective per se. Both in vitro and in vivo biochemical data have suggested that reduced expression of Acvrl1 or Gja5 altered reactive oxygen species production. 32, 33 To access the potential role of oxidative stress, reactive oxygen species production was measured by identifying dihydroethidium-positive nuclei in arteries of lung sections of 1-month-old control, Gja5 EGFP/+ , Acvrl1 +/− , or Acvrl1 +/− ; Gja5 EGFP/+ mice. Interestingly, greater dihydroethidium staining was observed in Acvrl1 +/− ; Gja5 EGFP/+ mice, suggesting higher O 2 − production ( Figure 4G ).
Basal Red Blood Cell Flow in Individual Capillaries of Acvrl1 +/− ; Gja5 EGFP/+ Mice
Reactive oxygen species production and reduced nitric oxide bioavailability have been reported to reduce endothelial cell survival leading to pruning of the microvasculature and contributing to the muscularization of the small arteries. 34 We observed a strong reduction in the density of the capillary bed ( Figure 5A and 5B) associated with a slight increase in capillary diameter ( Figure 5C ) in Acvrl1 +/− ; Gja5 EGFP/+ mice compared with control, Acvrl1 +/− , and Gja5 EGFP/+ mice. Capillary rarefaction is associated with local blood flow deregulation.
To examine whether this contributed to the vascular phenotype here, we used 2-photon microscopy to measure red blood cell (RBC) flow with micrometer spatial and millisecond temporal resolution in individual capillaries. 35 Retroorbital injection of red dextran revealed the vascular architecture of the ear skin and individual RBCs, which appeared as shadows flowing in the fluorescent plasma ( Figure 5D ). We used rapid line scans along the capillary axis to determine the instantaneous RBC flow ( Figure 5E ). We analyzed basal RBC flow in at least 29 capillaries that were located in a postarteriolar position in each genotype and detected all passing RBCs for 20 s (Figure 5F and 5G). Acvrl1 +/− ; Gja5 EGFP/+ mice showed an increase in basal RBC flow compared with control, Acvrl1 +/− , and Gja5 EGFP/+ mice, most likely reflecting an increase in blood flow ( Figure 5F and 5G ).
Reduced Cx40 Promotes Wound-Induced AVM Formation in Acvrl1 +/−
To explore the possibility that reduced expression of Cx40 might predispose to AVM formation in adult Acvrl1 +/− mice, we generated punch wounds in the ears of 3-month-old control, Acvrl1 +/− , Gja5 EGFP/+ , and Acvrl1 +/− ; Gja5 EGFP/+ mice. This type of wound induces environmental stress that triggers AVM formation in homozygous Acvrl1-iKO mice. 17, 36 Left ventricular injection of latex blue into the heart was performed 30 days after wounding to visualize arteriovenous connections in the skin. As expected, the blue latex did not cross the capillary bed and was retained within the arterial branches in control mice or Gja5 EGFP/+ mice ( Figure 6A ). Moreover, Acvrl1 +/− also showed normal morphology and latex only in arterial branches confirming that 3 events are required for AVM formation ( Figure 6A ). 10 By contrast, Acvrl1 +/− ; Gja5 EGFP/+ mice showed dilated and tortuous vessels, and the latex dye was found in both arteries and veins, indicating the presence of arteriovenous shunts (57%; n=7; Figure 6A ). Blood vessels away from the wound in Acvrl1 +/− ; Gja5 EGFP/+ mice had normal morphology and no arteriovenous shunts. We also stained whole mounts of mouse ears for platelet-endothelial cell adhesion molecule-1 and α-SMA 14 days after wounding. This staining showed that even at this stage, Acvrl1 +/− ; Gja5 EGFP/+ mice developed abnormal connections between arterioles and enlarged capillary-like vessels that were EGFP (+) forming a nidus ( Figure 6B ). Thus, our data identify Gja5 as a possible genetic modifier of HHT2 and provide proof-of-concept that genes implicated in blood flow regulation might have important functions during AVM formation.
Discussion
In this study, we identified Gja5 as a potential genetic modifier of AVMs in HHT2. Our work revealed that the BMP9/ALK1 signaling pathway targets Gja5 and that reduced expression of Gja5 in Acvrl1 heterozygous mutants leads to arterial vasodilation and rarefaction of the postarterial capillary network.
To normalize the changes in hemodynamic forces and drain the engorged arterial system, capillaries become enlarged and form transient arteriovenous connections that can develop into AVMs when exposed to environmental insults ( Figure 6C ). Our data suggest that Acvrl1 haploinsufficiency combined with the effects of modifier genes that regulate vessel caliber and blood flow is responsible for the heterogeneity and severity of the clinical manifestations in individuals with HHT2 and provide a novel 3-hit hypothesis model for AVM development.
Our data provide the first demonstration that changes in arterial vessel precede AVM formation in HHT mouse models, and importantly, we identify Gja5 as a potential modifier gene for HHT2. We report that the ALK1 signaling pathway stimulates the expression of Gja5, most importantly though BMP9. Reduced expression of Gja5 in Acvrl1 heterozygous mice results in enlarged arterial vessels, altered blood flow, and the formation of transient arteriovenous shunts in the capillary bed; these can remodel into large AVMs where there is a proangiogenic and proinflammatory environment. Our findings are consistent with recent work showing that loss of Acvrl1 in zebrafish embryos leads to pathological arterial enlargement and consequently altered blood flow to induce lethal AVM formation. 19 Acvrl1 +/− ; Gja5 EGFP/+ double heterozygous mice provide a novel genetic model in which AVMs develop consistently and robustly. Most importantly, the AVMs resemble those seen in patients with HHT, making this model an invaluable tool for uncovering the molecular and cellular defects that lead to vascular malformations in HHT, in particular those related to blood flow alterations. The Gja5 gene encodes for Cx40, a gap junction protein expressed in the developing arterial network, starting at the onset of perfusion. 37 In the vascular system, endothelial cells predominantly express Cx37 (Gja4) and Cx40, whereas vascular smooth muscle cells mostly express Cx43 (Gja1) and Cx45 (Gjc1). Gap junction proteins form channels between neighboring cells to allow direct intercellular exchanges of ions and small metabolites, which are needed to coordinate vasoconstriction and vasodilation along the vessels. 38, 39 Genetic studies show that mice lacking Cx40 develop hypertension because of increased secretion of renin and reduced relaxation of peripheral vessels. 40 These defects have recently been shown to be at least partially dependent on endothelial Cx40 function indicating that Cx40 expression levels regulate blood pressure. How endothelial Cx40 controls blood pressure remains poorly understood but might be attributable to endothelial nitric oxide synthase activity, an important modulator of vascular tone. 40 Interestingly, both ALK1 and Cx40 interact and regulate the activity of endothelial nitric oxide synthase, 33, 41 suggesting that the phenotype of the Acvrl1 +/− ; Gja5 EGFP/+ mice may be at least partially attributable to uncoupled endothelial nitric oxide synthase activity. To support this hypothesis, we have found an increase production of reactive oxygen species in the lung arteries of Acvrl1 +/− ; Gja5 EGFP/+ mice. Mice carrying deletions in Gja5 also have fewer collateral arterioles, 37 whereas Gja4 −/− ; and Acvrl1 +/− ; Gja5a EGFP (n=7) mice stained 2 weeks after wounding for platelet-endothelial cell adhesion molecule-1 (PECAM-1) marking endothelial cells in red and for α-smooth muscle actin (α-SMA; vascular smooth muscle cells in green) or labeled in enhanced green fluorescent protein (EGFP) to identity the arteries. The white arrow indicates the formation of a system of multiple feeding arteries, the tangle or nidus and enlarged draining veins in Acvrl1 +/− ; Gja5a EGFP . C, Working model for AVM formation in hereditary hemorrhagic telangiectasia type 2 (HHT2). Heterozygosity of Acvrl1 represents the baseline situation in HHT2. The vascular network shows distinguishable arteries and veins separated by a highly branched vascular plexus. Pathological enlargement of the arterial vessels results in the delivery of more blood volume to the downstream capillaries that adapt by enlarging and by forming transient AV shunts. Sustained angiogenesis promotes further the enlargement of these AV shunts that may form large AVMs. a indicates arteries; and v, veins.
Gja5 −/− double-knockout mice die in utero, showing angiogenic remodeling defects with dilated blood vessels and hemorrhages, 42 suggesting that Cx40 might regulate angiogenesis. Loss of Acvrl1 expression results in excessive endothelial cell proliferation that precedes the development of arteriovenous shunts in zebrafish 19 and in Acvrl1-iKO mice. 17 Here, we show that reduced expression of Gja5 in Acvrl1 heterozygous embryos and in neonatal retinas of postnatal day 7 mice leads to significant vasodilation of the arteries and markedly reduced numbers of postarterial branches. In contrast to Acvrl1 +/− mutant mice, we did not observe excessive endothelial proliferation in Acvrl1 +/− ; Gja5 EGFP/+ mice. Defective angiogenesis may, therefore, be the primary event responsible for this arterial enlargement, although the mechanisms that account for this observation-decreased arterial growth, retarded migration, and defective endothelial sprouting-remain to be elucidated. The presence of dilated arteries that deliver more blood induces the enlargement of the downstream Cx40-independent capillary-like vessels to drain this system and the formation of arteriovenous connections. This enlargement is accompanied by increased endothelial proliferation suggesting that the presence of flow stimulates further the remodeling of the capillary bed, a mechanism that might be independent of Cx40. Furthermore, loss of Acvrl1 in zebrafish has previously been shown to result in increased expression of cxcr4a and decreased expression of edn1, suggesting that ALK1 might promote the quiescence of nascent arteries by alternative mechanisms. 19 Given the fact that these genes encode a proangiogenic chemokine receptor and a vasoconstrictive peptide, respectively, it is logical to consider that they may regulate arterial caliber downstream of ALK1. Nevertheless, concomitant increase in cxcr4a and loss of edn1 in zebrafish embryos did not copy the lack of Acvrl1 and were not sufficient to generate AVMs. 19 Genetic polymorphisms have been detected in both promoter regions of GJA5 and suspected to be associated with risk of cardiovascular diseases, including hypertension. 39 These polymorphisms have been shown to affect GJA5 promoter activity by reducing gene expression by approximately half with interassay variations ranging from 20% to 65% reduction. By comparing the expression levels of Cx40 in sections of human skin biopsies isolated from 5 healthy donors and 4 patients with HHT2, we have confirmed that important differences exist between individuals, and more importantly, we reveal that Cx40 protein levels are particularly low in the majority of a small selection of patients with HHT2 compared with the healthy donors supporting an association between ALK1 signaling and Cx40 expression.
In conclusion, our findings provide novel insights into the mechanisms underlying AVM pathogenesis in HHT2 elicited by increased arterial caliber that might ultimately be used for drug development for HHT. Moreover, we identity GJA5 as a potential modifier gene for HHT2 in which genetic variations, such as polymorphisms affecting normal expression levels, are associated with disease progression.
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